Idera Pharmaceuticals is a clinical-stage patient-focused biopharmaceutical company developing novel nucleic acid therapeutic approaches for the treatment of certain cancers and rare diseases. Idera’s immunotherapy approach is based on the modulation of toll-like receptors (TLRs) while our third-generation antisense technology is designed to inhibit the production of disease-associated proteins by targeting RNA.
The Clinical Scientist role is an exciting opportunity for a highly motivated individual to contribute to the development and execution of the clinical strategy and plans for Idera’s Immuno-oncology programs.
Through extensive interaction with the Medical Lead and the rest of the clinical development team, this individual will have an opportunity to make an impact through strategic and scientific input as well as scientific support of Idera’s clinical programs. He/she will use the scientific knowledge and experience to help Idera build clinical expertise in the Oncology therapeutic area.
More specifically, this role collaborates with the Oncology Medical Lead and others on the team to design, plan, and implement the overall direction of clinical research projects including development of study specific documents such as protocols and informed consents, regulatory documents as well as performing data review and analyzes and assisting with site training activities.
The clinical scientist works closely with site staff and CRO’s to ensure adherence to study protocols and assists the medical team with answering protocol related questions from sites and other team members.
The Staff Accountant will assist in accurately maintaining the Company’s accounting records and documentation, including SOX 404 documentation, support the Company’s external reviews and audits and assist in budgeting and forecasting, as assigned.
Idera has an exciting opportunity for a highly collaborative individual to join our team and impact the long-term value of Idera’s lead immune-oncology asset, tilsotolimod. The Regulatory Affairs Lead will provide regulatory expertise, direction, and operational oversight of the tilso program, including its ongoing Ph 3 trial in metastatic melanoma and follow on trials in subsequent indications. This role will also collaborate closely and effectively with the cross-functional study/project team in contributing to the development of overall product development strategies for the tilsotolimod program. This position will work from Idera's greater-Philadelphia location in Exton PA.